GlassScriptPhysician profile
Osbert Fernandez
NPI 1740252477
$12,295.42
in general payments reported to CMS, 2019-2025
25 companies · $2,283 in 2025
The $2,283 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $127 · 2021: $683 · 2022: $1,352 · 2023: $1,409 · 2024: $6,212 · 2025: $2,283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,539 · Travel and Lodging: $3,365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,539.30 |
| Travel and Lodging | $3,365.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $8,935.63 | 2022-2025 | Xeomin |
| Abbvie INC. | $852.00 | 2019-2024 | |
| Galderma Laboratories, L.P. | $538.43 | 2021-2025 | |
| Allergan, INC. | $478.08 | 2019-2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $162.13 | 2024-2025 | Clear+Brilliant |
| Astellas Pharma US INC | $141.16 | 2023-2025 | Veozah, Myrbetriq |
| Evofem Biosciences, INC. | $133.48 | 2021-2024 | Phexxi |
| Medtronic, INC. | $132.43 | 2023 | Truclear |
| Bayer Healthcare Pharmaceuticals INC. | $120.96 | 2022-2025 | |
| Mayne Pharma Commercial LLC | $120.03 | 2021-2025 | |
| Lsi Solutions INC | $111.35 | 2025 | Cor-Knot |
| Agile Therapeutics, INC. | $96.68 | 2021-2022 | |
| Hologic Sales and Service, LLC | $66.38 | 2021-2025 | Myosure Tissue Removal Device, Novasure |
| Coopersurgical, INC. | $54.17 | 2021-2024 | Summit Doppler |
| Avion Pharmaceuticals | $52.63 | 2019-2023 | Balcoltra |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $51.57 | 2020-2021 | |
| Exeltis, USA INC. | $50.47 | 2019-2020 | |
| Organon LLC | $46.08 | 2021-2025 | Nexplanon |
| Lupin INC. | $42.68 | 2019-2020 | |
| Novo Nordisk INC | $34.31 | 2023-2024 | Wegovy |
| Lilly USA, LLC | $17.04 | 2024 | Zepbound |
| Vivus LLC | $17.00 | 2023 | Qsymia |
| Meditrina | $15.69 | 2023 | |
| Minerva Surgical, INC | $12.62 | 2022 | |
| Scynexis, INC. | $12.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Osbert Fernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.